CytomX Therapeutics CTMX
NASDAQ CTMX
$2.43 -0.08 (-3.19%)
As of: Oct 21, 2026 · 2:27 PM EDT

CytomX Therapeutics (CTMX) Other financing activities (2015 - 2016)

Updated

Analysis

CytomX Therapeutics (CTMX) Other financing activities (2015 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn
10 CytomX Therapeutics 535.31 Mn -422.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 -12,000.00
Sep 30, 2015 -1.07 Mn
API Access

CytomX Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CTMX&period=max&api_key=YOUR_API_KEY